MODERN MODEL FORMATION OF DRUG PROVISION OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN KABARDINO-BALKARIA
https://doi.org/10.19163/2307-9266-2019-7-3-158-169
Abstract
The increase in the incidence of community-acquired pneumonia (СAP) is a major problem of national and regional importance. Its pharmacotherapy is based on the active use of antibacterial drugs. That requires a special attention of both, a doctor and a patient, the search for all new and advanced medicines (drugs).
The aim of the study is to justify and develop a regional model of drug provision of pharmacotherapy in community-acquired pneumonia.
Materials and methods. The use of the resource approach and the methodology of pharmaceutical care (PhC) for the formation of a modern model of drug supply have been tested. Logical, retrospective, sociological, pharmacoeconomic, marketing, statistical and other analytical methods have been used. The materials were official statistics, literature data and the results of the research carried out by the authors themselves.
Results. The state and tendencies of development of organizational, personnel, financial (population) and drug resources as the external factors affecting PhC to patients with CAP in the Kabardino-Balkarian Republic (KBR) have been identified. The following internal factors of PhC have been defined: medical prescriptions, consumer demands and the cost of pharmacotherapy. A model of drug provision for patients with CAP in the region has been formed. It is aimed at increasing the effectiveness of treatment, taking into account the stage of treatment and the price factor.
Conclusion. Under the conditions of a particular region, the use of the resource approach and the PhC methodology allows to more accurately identify the problems and risks of both drug provision and pharmacotherapy of the patients’ population under study, and form a model adequate to reality, develop recommendations for all participants of PhC – a doctor, a patient and a pharmaceutist (a pharmacist).
About the Authors
A. A. UmirovaRussian Federation
postgraduate student, Department of Economics and Organization of Healthcare and Pharmacy,
11, Kalinin ave., Pyatigorsk, 357532
V. L. Adzhienko
Russian Federation
Doctor of Sciences (Medicine), Professor, Head of the Department of Economics and Organization of Healthcare and Pharmacy,
11, Kalinin ave., Pyatigorsk, 357532
T. I. Kabakova
Russian Federation
Doctor of Sciences (Pharmacy), Associate Professor, Professor at the Department of Organization and Economics of Pharmacy,
11, Kalinin ave., Pyatigorsk, 357532
E. A. Korzhavykh
Russian Federation
Doctor of Sciences (Pharmacy),
Block 2, 10, Miklukho-Maklay St., Moscow, 117198
V. V. Gatsan
Russian Federation
Doctor of Sciences (Pharmacy), Professor, Head of the Department of Organization and Economics of Pharmacy,
11, Kalinin ave., Pyatigorsk, 357532
References
1. Karapetyan TA. Vnebol’nichnaya pnevmoniya segodnya [Community-Acquired pneumonia today]. Bulletin of St. Petersburg University. Series 11: Medicine. 2008;1:1–14. Russian
2. Sinopal’nikov AI, Strachunskij NS. Novye rekomendacii po vedeniyu vzroslyh pacientov s vnebol’nichnymi pnevmoniyami [New guidelines for the management of adult patients with community-acquired pneumonia]. Clinical Microbiology and antimicrobial therapy. 2000; 3(1):54–58. Russian
3. Kabardino-Balkaria in numbers. 2018. Summary of statistics. OP North Caucasus stat on CBD-N. – Nalchik, 2018. – 183 p. Russian
4. Regions of Russia. Socio-economic indicators. 2018: Stat. SB. Rosstat. 2018: 1162 p. Russian
5. Russian statistical yearbook. 2018: Stat.SB. Rosstat. – M., 2018:694. Russian
6. Health in Russia. 2017: Stat.SB. Rosstat. – M., 2017:170. Russian
7. Health in Russia. 2009: Stat.SB. Rosstat. – M., 2009:365. Russian
8. Ponomareva AA, Mozgovaya NA, Zhukova OV. Ocenka effektivnosti antibakterial’noj terapii vnebol’nichnoj pnevmonii u detej na osnove farmakoekonomicheskogo analiza [Assessment of efficiency of antibacterial therapy of community-acquired pneumonia in children on the basis of pharmacoeconomic analysis]. Medical. almanac. 2011. Special issue, March 2011: 204–205. Russian
9. Yakovlev SV. Vnebol’nichnaya pnevmoniya u pozhilyh. Osobennosti etiologii, klinicheskogo techeni ya i antibakterial’noj terapii [Community-Acquired pneumonia in the elderly. Features of etiology, clinical course and antibacterial therapy]. Russian medical journal. 1999;7(16):763–768. Russian
10. Barlett JG, Breiman RF, Mandell LA, File TM. Community-Acquired Pneumonia in Adults: Guidelines for Management. Clinical Infectious Diseases. 1998; 28: 811–838.
11. Niederman MS, Mandell LA, Anzueto A. Guidelines for management of adults with community-acquired pneumonia. Diagnosis, assessment of severity antimicrobial therapy, and prevention. The official statement of the American Thoracic Society was approved by the ATC board of directors. Am. J. Respir. Crit. Care Med. 2001;163:1730–1754. DOI: 10.1164/ajrccm.163.7.at1010
12. Yabachinskaya EN. Vozbuditeli vnebol’nichnyh pnevmonij na poroge novogo tysyacheletiya [Pathogens of community-acquired pneumonia at the threshold of the new Millennium]. Antibiotics and chemotherapy. 2000; 45(11):21–28. Russian
13. Dvoreckij LI, Yakovlev SV. Oshibki antibakterial’noj terapii infekcij dyhatel’nyh putej v ambulatornoj praktike [Errors of antibacterial therapy of respiratory tract infections in outpatient practice]. The Attending physician. 2003;8:48–54. Russian
14. Hristolyubova EI, Volkova LI. Oshibki v diagnostike vnebol’nichnyh pnevmonij na dogospital’nom etape [Errors in the diagnosis of community-acquired pneumonia at the prehospital stage]. Therapeutic archive. 2005;3:33–36. Russian
15. Hristolyubova EI, Volkova LI. Oshibki diagnostiki i lecheniya pnevmonij v poliklinicheskih usloviyah [Errors in diagnosis and treatment of pneumonia in polyclinic conditions]. Therapeutic archive. 2005;1:8–12. Russian
16. Panfіlova GL. Farmacevtichna dopomoga yak іstorichna, normativno-pravova ta socіal’no-ekonomіchna kategorіya v sistemі ohoroni zdorov’ya і farmacevtichnomu zabezpechennі naselennya [Pharmaceutical assistance as a historical, legal and socio-economic category in the system of health protection and pharmaceutical provision of the population]. Topical issues of pharmaceutical and medical science and practice. 2014;2 (15): 89–97. Russian
17. Apikoglu-Rabus S, Yesilyaprak G, IzzettinF.V Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir. Med. 2016; 120:109–115. DOI:10.1016/j.rmed.2016.10.006
18. Helper CD. The future of pharmacy pharmaceutical care. Am. J. Hosp. Pharm. 1990;30:23–29.
19. Kassam R, Collins JB, Berkowitz J. Patient satisfaction with pharmaceutical care delivery in community pharmacies.Patient Preference and Adherence. 2012;6:337-348. DOI: 10.2147/PPA.S29606.
20. Presley B, Setiabudi I, Lestiono L, Ediyono E. The Influence of Pharmaceutical Care Intervention on Inpatient Community Acquired Pneumonia: a Small Randomized Single Blind Study. J. Sains Farmasi & Klinis. 2015;2(1):84–90. DOI: https://doi.org/10.29208/jsfk.2015.2.1.54
21. KonT, MoriM, HashimotoT. Pharmaceutical Care Approach to Treating Pneumonia among the Elderly with Intravenous Azithromycin.Iryo Yakugaku (Jap. J. of Pharm. Health Care a. Sci.). 2016; 42(9):634–644. DOI.org/10.5649/jjphcs.42.634
22. Wang YH, Fang J, Zhu BD. Pharmaceutical care of a patient with severe pneumonia complicated with Parkinson’s disease. Pharm. Care a. Research. 2013; 13(2);136–139. DOI: 10.5428/pcar20130219
23. Dremova NB, Alekseev IV. Analiz medicinskoj i farmacevticheskoj informirovannosti VICH-inficirovannyh pacientov [Analysis of medical and pharmaceutical knowledge of HIV-infected patients]. Scientific. statements BSU. Ser. «Medicine. Pharmacy» .2012; 17(4): P. 39–44. Russian
24. Dremova NB, Ovod AI, Korzhavyh EA, Litvinova TM. Farmacevticheskaya pomoshch’: termin i ponyatie [Pharmaceutical assistance: term and concept]. Pharmacy. 2005; 2: 37–45. Russian
25. Korzhavykh EA, Moshkova LV, SHukil’ LV. Metodologicheskie aspekty rossijskih issledovanij po farmacevticheskoj pomoshchi [Methodological aspects of Russian researches on pharmaceutical care]. Pharmacy. 2016;1:39–42. DOI: https://doi.org/NoneRussian
26. Dremova NB, Ovod AI, Korzhavyh EA, Litvinova TM. Farmacevticheskaya pomoshch’ – novoe napravlenie professional’noj deyatel’nosti provizora [Pharmaceutical assistance – a new direction of professional activity of pharmacist]. New pharmacy. 2005;10: 20–28. Russian
27. Mymrina AL, Geller LN, Tueva IA. Klasternyj podhod kak osnova processa okazaniya farmacevticheskoj pomoshchi na etape reanimacii i intensivnoj terapii [Cluster approach as the basis of the process of pharmaceutical care at the stage of resuscitation and intensive care]. Pharmacy. 2012;7: 24–26. Russian
28. Petrov AG, Knysh OI, Petrov GP. Farmakoekonomicheskaya ocenka farmakoterapii pri lechenii professional’nogo obstruktivnogo bronhita shahterov na stacionarnom urovne [Pharmacoeconomical evaluation of pharmacotherapy in the treatment of occupational obstructive bronchitis of miners at the stationary level]. Health and education in the XXI century.2017;19(2):113–116. Russian
29. Kabakova TI, Umirova AA, Korzhavyh EA. Vyyavlenie i analiz vektorov razvitiya sovremennyh issledovanij po farmacevticheskoj pomoshchi [Identification and analysis of vectors of development of modern research on pharmaceutical care]. Eurasian Scientific Association (ENO). 2019;4 (50):177–183. Russian
30. Spichak IV, Varenykh GV. Sovershenstvovanie farmacevticheskoj pomoshchi detyam s narusheniyami CNS v usloviyah stacionara na primere Belgorodskoj oblasti [Improvement of pharmaceutical care for children with CNS disorders in a hospital on the example of Belgorod region]. Scientific statement BSU. Ser. Medicine. Pharmacy. 2013;153(22):71–78. Russian
31. Spichak IV, Derekglazova YUS. Sovershenstvovanie farmacevticheskoj pomoshchi detyam s zabolevaniyami sustavov na territorii Belgorodskoj oblasti [Improvement of pharmaceutical care of children with diseases of the joints on the territory of Belgorod region]. Scientific statement BSU. Ser. Medicine. Pharmacy. 2013.;154(22):39–46. Russian
32. Trubina LV, Pen’evskaya NA. Sovershenstvovanie farmacevticheskoj pomoshchi klientam aptek po voprosam profilaktiki infekcij, perenosimyh iksodovymi kleshchami [Improvement of pharmaceutical care to clients of pharmacies in the prevention of infections transmitted by Ixodes ticks]. Fundamental research. 2014; 11:1333–1339. Russian
33. Yachnikova MA. Sovremennye podhody k organizacii farmacevticheskogo konsul’tirovaniya klienta aptek, priobretayushchego antiseptiki dlya lecheniya boli v gorle [Modern approaches to the organization of pharmaceutical counseling of client pharmacies acquiring antiseptics for the treatment of pain in the throat]. Omsk scientific. bulletin. Sir. «Earth resources. Man.». 2012; 2 (114): 89–91. Russian
34. Zakaryaeva ZT, Andreeva IN. Osobennosti lekarstvennogo obespecheniya bol’nyh pnevmoniyami na etape stacionarnogo lecheniya v RSO-Alaniya [Peculiarities of provision of medicines of patients with pneumonia at the stage of inpatient treatment in RSO-Alania]. Modern problems of science and education. 2013; 3. URL: https://science-education.ru/ru/article/view?id=9549Russian
35. Zemskova NA, Loskutova EE. Nekotorye farmakoekonomicheskie aspekty netyazheloj vnebol’nichnoj pnevmonii. Assortiment antibakterial’nyh preparatov v aptekah [Some pharmacoeconomical aspects of mild community-acquired pneumonia. The range of antibacterial drugs in pharmacies]. Bulletin of the Russian University of friendship of peoples. 2007:62–64. Russian
36. Bell JS, Väänänen M, Ovaskainen H. Providing Patient Care in Community Pharmacies: Practice and Research in Finland. Ann. Pharmacother. 2007; 41 (6):1039–1046. DOI.org/10.1345/aph.1H638
37. Besançon L. Pharmaceutical Care. Summary of a survey from the Council of Europe. FIP.2010:32.
38. Perraudin C, Brion F, Bourdon O, Pelletier-Fleury N. The future of pharmaceutical care in France: a survey of final-year pharmacy students’ opinions. BMC Clin. Pharmacol. 2011; 11:6 doi: 10.1186 / 1472- 6904-11-6 DOI: 10.1186/1472-6904-11-6.
39. Curtiss FR. Clinical Pharmacist Interventions Associated with Appropriateness and Lengthof Inpatient Antimicrobial Therapy for Pneumonia. J. Manag. Care Spec. Pharm. 2002; 8(5):406–406. DOI: 10.18553/jmcp.2002.8.5.406
40. Dzhuparova IA. Tipologiya farmacevticheskoj pomoshchi l’gotnym kategoriyam grazhdan v Sibirskom federal’nom okruge [Typology of pharmaceutical care preferential categories of citizens in the Siberian Federal Region]. Medicine and education in Siberia. 2010;5:10–18. Russian
41. Dzhuparova IA, Sboeva SG. Tipologiya farmacevticheskoj pomoshchi otdel’nym kategoriyam grazhdan v Sibirskom federal’nom okruge [Typology of pharmaceutical care to separate categories of citizens in the Siberian Federal district]. Bulletien of the Voronezh state University. Ser.: Chemistry. Biology. Pharmacy. 2010;2:140–143. Russian
42. Shukil’ LV. Opyt okazaniya specializirovannoj farmakologicheskoj pomoshchi bol’nym saharnym diabetom v Omskoj oblasti [Experience in providing specialized pharmaceutical care for patients with diabetes in the Omsk region]. Sib. Med. journal. (Irkutsk.) 2013; 118(3): 94–96 Russian
43. Fomina AV, Moshkova LV. Dostupnost’ lekarstvennoj pomoshchi naseleniyu: faktory vliyaniya [Availability of medical care to the population: factors of influence]. New pharmacy. The Director of pharmacy. 2004;3: 48–52. Russian
Review
For citations:
Umirova A.A., Adzhienko V.L., Kabakova T.I., Korzhavykh E.A., Gatsan V.V. MODERN MODEL FORMATION OF DRUG PROVISION OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN KABARDINO-BALKARIA. Pharmacy & Pharmacology. 2019;7(3):158-169. https://doi.org/10.19163/2307-9266-2019-7-3-158-169